Market Overview:
The global ceftizoxime sodium API market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for ceftizoxime sodium API in various applications such as Ceftizoxime Sodium Injection and other applications. North America is expected to dominate the global ceftizoxime sodium API market during the forecast period, followed by Europe and Asia Pacific.
Product Definition:
Ceftizoxime Sodium API is an antibiotic used to treat a variety of infections. It works by stopping the growth of bacteria.
Purity ≥ 98 %:
Ceftizoxime sodium is a white crystalline compound derived from oximes. It's used for the treatment of bacterial meningitis and septicaemia, as well as urinary tract infections (UTIs). The drug has a wide spectrum of activity against gram-positive and negative bacteria.
Purity ≥ 99 %:
Ceftizoxime sodium is a white crystalline compound and has a molecular weight of 464.5. It is soluble in water, ethanol, and diethyl ether but not in chloroform or other organic solvents. The product was first registered by Upjohn Co., Inc., as an anti-invectives agent under the trade name Zioxan by USP-NF which contains Ceftizoxime sodium as the active ingredient.
Application Insights:
Ceftizoxime sodium injection was the largest application segment in 2017 and accounted for over 60.0% of the total revenue share. Ceftizoxime sodium is an antibiotic that is used to treat a wide range of bacterial infections, including respiratory tract infections, skin & soft tissue infections, urinary tract infections and gastrointestinal (GI) illnesses such as diarrhea caused by E. coli or Salmonella species. The product also has usage in veterinary medicine for animal treatment purposes against bacterial diseases such as pneumonia and meningitis due to Escherichia coli O157:H7 infection among others.
Regional Analysis:
Europe dominated the global market in terms of revenue in 2017. The presence of well-established healthcare facilities, high patient awareness levels coupled with relatively higher healthcare expenditure levels in this region are some major factors accounting for its large share.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to increasing demand for antibiotics as a result of rising prevalence of infectious diseases and growing geriatric population that require long term treatment with antibiotics. Moreover, economic development and improvement in living standards have led to an increase in consumer spending on medical treatments, which is anticipated to fuel the regional market growth over the forecast period.
Growth Factors:
- Increasing demand for ceftizoxime sodium API in the pharmaceutical industry as a result of its efficacy in treating various types of infections.
- Rising prevalence of infectious diseases and growing awareness about the benefits of ceftizoxime sodium API over traditional antibiotics is expected to fuel the growth of this market during the forecast period.
- Growing number of research and development activities for new drug formulations using ceftizoxime sodium API is projected to create lucrative opportunities for market players in this segment during the forecast period.
- Technological advancements that have led to introduction of novel dosage forms such as injectable and intravenous drugs are anticipated to boost demand for ceftizoxime sodium API globally over the next few years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Ceftizoxime Sodium API Market Research Report
By Type
Purity ≥ 98 %, Purity ≥ 99 %
By Application
Ceftizoxime Sodium Injection, Other
By Companies
Sterile India, Hangzhou Viwa, Sinopharm Weiqida Pharmaceutical, Qilu Pharmaceutial, Orchid Pharma, Parabolic Drugs, Luoxin Pharmaceutical, Hanmi Fine Chemical, SPC Pharma, Shamshree Lifesciences, Sterile India
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
149
Number of Tables & Figures
105
Customization Available
Yes, the report can be customized as per your need.
Global Ceftizoxime Sodium API Market Report Segments:
The global Ceftizoxime Sodium API market is segmented on the basis of:
Types
Purity ≥ 98 %, Purity ≥ 99 %
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Ceftizoxime Sodium Injection, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sterile India
- Hangzhou Viwa
- Sinopharm Weiqida Pharmaceutical
- Qilu Pharmaceutial
- Orchid Pharma
- Parabolic Drugs
- Luoxin Pharmaceutical
- Hanmi Fine Chemical
- SPC Pharma
- Shamshree Lifesciences
- Sterile India
Highlights of The Ceftizoxime Sodium API Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Purity ≥ 98 %
- Purity ≥ 99 %
- By Application:
- Ceftizoxime Sodium Injection
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Ceftizoxime Sodium API Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Ceftizoxime Sodium API is an antibiotic used to treat a variety of bacterial infections. It is available as a tablet or liquid form.
Some of the major players in the ceftizoxime sodium api market are Sterile India, Hangzhou Viwa, Sinopharm Weiqida Pharmaceutical, Qilu Pharmaceutial, Orchid Pharma, Parabolic Drugs, Luoxin Pharmaceutical, Hanmi Fine Chemical, SPC Pharma, Shamshree Lifesciences, Sterile India.
The ceftizoxime sodium api market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Ceftizoxime Sodium API Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Ceftizoxime Sodium API Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Ceftizoxime Sodium API Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Ceftizoxime Sodium API Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Ceftizoxime Sodium API Market Size & Forecast, 2018-2028
4.5.1 Ceftizoxime Sodium API Market Size and Y-o-Y Growth
4.5.2 Ceftizoxime Sodium API Market Absolute $ Opportunity
Chapter 5 Global Ceftizoxime Sodium API Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Ceftizoxime Sodium API Market Size Forecast by Type
5.2.1 Purity ≥ 98 %
5.2.2 Purity ≥ 99 %
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Ceftizoxime Sodium API Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Ceftizoxime Sodium API Market Size Forecast by Applications
6.2.1 Ceftizoxime Sodium Injection
6.2.2 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Ceftizoxime Sodium API Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Ceftizoxime Sodium API Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Ceftizoxime Sodium API Analysis and Forecast
9.1 Introduction
9.2 North America Ceftizoxime Sodium API Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Ceftizoxime Sodium API Market Size Forecast by Type
9.6.1 Purity ≥ 98 %
9.6.2 Purity ≥ 99 %
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Ceftizoxime Sodium API Market Size Forecast by Applications
9.10.1 Ceftizoxime Sodium Injection
9.10.2 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Ceftizoxime Sodium API Analysis and Forecast
10.1 Introduction
10.2 Europe Ceftizoxime Sodium API Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Ceftizoxime Sodium API Market Size Forecast by Type
10.6.1 Purity ≥ 98 %
10.6.2 Purity ≥ 99 %
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Ceftizoxime Sodium API Market Size Forecast by Applications
10.10.1 Ceftizoxime Sodium Injection
10.10.2 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Ceftizoxime Sodium API Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Ceftizoxime Sodium API Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Ceftizoxime Sodium API Market Size Forecast by Type
11.6.1 Purity ≥ 98 %
11.6.2 Purity ≥ 99 %
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Ceftizoxime Sodium API Market Size Forecast by Applications
11.10.1 Ceftizoxime Sodium Injection
11.10.2 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Ceftizoxime Sodium API Analysis and Forecast
12.1 Introduction
12.2 Latin America Ceftizoxime Sodium API Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Ceftizoxime Sodium API Market Size Forecast by Type
12.6.1 Purity ≥ 98 %
12.6.2 Purity ≥ 99 %
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Ceftizoxime Sodium API Market Size Forecast by Applications
12.10.1 Ceftizoxime Sodium Injection
12.10.2 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Ceftizoxime Sodium API Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Ceftizoxime Sodium API Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Ceftizoxime Sodium API Market Size Forecast by Type
13.6.1 Purity ≥ 98 %
13.6.2 Purity ≥ 99 %
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Ceftizoxime Sodium API Market Size Forecast by Applications
13.10.1 Ceftizoxime Sodium Injection
13.10.2 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Ceftizoxime Sodium API Market: Competitive Dashboard
14.2 Global Ceftizoxime Sodium API Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Sterile India
14.3.2 Hangzhou Viwa
14.3.3 Sinopharm Weiqida Pharmaceutical
14.3.4 Qilu Pharmaceutial
14.3.5 Orchid Pharma
14.3.6 Parabolic Drugs
14.3.7 Luoxin Pharmaceutical
14.3.8 Hanmi Fine Chemical
14.3.9 SPC Pharma
14.3.10 Shamshree Lifesciences
14.3.11 Sterile India
